From: Trends in drug-drug interactions for new drug clinical trials in China over the past 10 years (2013–2022)
Number
Investigational drug start (Day)
Investigational drug end (Day)
The first dose of digoxin (Day)
The second dose of digoxin (Day)
CTR20****52
6
15
1
10
CTR20****64
27
22
CTR20****18
14
CTR20****86
7
26
3
23
CTR20****21
5
16
12